alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › progression

progression

6 studies tagged progression, dated 2009-02-01 to 2023-08-03. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Dysregulation of Ruminococcaceae and Megamonas could be predictive markers for rapid progression of mild cognitive impairment 2023-08-03
  2. CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers 2022-11-10
  3. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type 2022-07-01

Studies

6 studies carry this tag.

Date range

2009 to 2023

Top journals

  • Brain : a journal of neurology 1
  • Clinical microbiology reviews 1
  • Journal of neurology, neurosurgery, and psychiatry 1
  • Journal of proteome research 1
  • Microbial pathogenesis 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Dysregulation of Ruminococcaceae and Megamonas could be predictive markers for rapid progression of mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Microbial pathogenesis 2023-08-03 Biomarkers

    The decrease of Ruminococcaceae and the increase of Megamonas could act as predictive markers for the rapidly progressive MCI.

  2. CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of neurology, neurosurgery, and psychiatry 2022-11-10 Biomarkers

    CSF markers of iron and neuroinflammation have distinct associations with disease stages, while iron may be more intimately associated with apolipoprotein E and tau pathology.

  3. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Brain : a journal of neurology 2022-07-01 Biomarkers

    Alzheimer's disease has a long asymptomatic phase that offers a substantial time window for intervention.

  4. Cerebrovascular pathology during the progression of experimental Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2016-01-08 Biomarkers

    Clinical and experimental evidence point to a possible role of cerebrovascular dysfunction in Alzheimer's disease (AD).

  5. Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Clinical microbiology reviews 2015-07-01 Biomarkers

    Toxocara canis and T. cati are highly prevalent nematode infections of the intestines of dogs and cats.

  6. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of proteome research 2009-02-01 Biomarkers

    Alzheimer's disease (AD) is the most common type of dementia, comprising 60-80% of all reported cases, and currently affects 5.2 million Americans.

All topic tags with their study counts